PNC FINANCIAL SERVICES GROUP, INC. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$423,747
+13.8%
4,156
+1.5%
0.00%
Q1 2023$372,408
+135.4%
4,096
-1.7%
0.00%
Q4 2022$158,228
+53.6%
4,165
+1.7%
0.00%
Q3 2022$103,000
-16.9%
4,096
-0.1%
0.00%
Q2 2022$124,000
-6.1%
4,102
+1.5%
0.00%
Q1 2022$132,000
+22.2%
4,042
-1.5%
0.00%
Q4 2021$108,000
-89.4%
4,105
-59.4%
0.00%
-100.0%
Q3 2021$1,017,000
-29.0%
10,112
-0.1%
0.00%0.0%
Q2 2021$1,433,000
+41.2%
10,126
-0.7%
0.00%0.0%
Q1 2021$1,015,000
-19.6%
10,194
-0.1%
0.00%0.0%
Q4 2020$1,262,000
+27.5%
10,204
+0.3%
0.00%0.0%
Q3 2020$990,000
-42.8%
10,171
-8.3%
0.00%
-50.0%
Q2 2020$1,730,000
+5.6%
11,088
-2.3%
0.00%0.0%
Q1 2020$1,638,000
-27.5%
11,346
+2.7%
0.00%0.0%
Q4 2019$2,258,000
+179.5%
11,046
+9.8%
0.00%
+100.0%
Q3 2019$808,000
-15.1%
10,064
-0.2%
0.00%0.0%
Q2 2019$952,000
+10.4%
10,0880.0%0.00%0.0%
Q1 2019$862,000
+52.6%
10,088
+0.4%
0.00%0.0%
Q4 2018$565,000
-31.1%
10,049
+0.1%
0.00%0.0%
Q3 2018$820,000
+133.0%
10,0380.0%0.00%
Q2 2018$352,000
+70.9%
10,0380.0%0.00%
Q1 2018$206,000
-27.5%
10,0380.0%0.00%
Q4 2017$284,000
-9.0%
10,038
+0.4%
0.00%
Q3 2017$312,000
-1.3%
10,0000.0%0.00%
Q2 2017$316,000
+39.8%
10,0000.0%0.00%
Q1 2017$226,000
+3.7%
10,0000.0%0.00%
Q4 2016$218,000
-17.4%
10,0000.0%0.00%
Q3 2016$264,000
+33.3%
10,0000.0%0.00%
Q2 2016$198,00010,0000.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders